John Tomaro
Chief Tech/Sci/R&D Officer at BOLT BIOTHERAPEUTICS, INC.
Network origin in John Tomaro first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 24 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John Tomaro via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CINCOR PHARMA, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree Masters Business Admin | |
| University of Mumbai | College/University | Undergraduate Degree Undergraduate Degree | |
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Founder Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| SOLENO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor Founder | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| OBSEVA SA | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| CORVUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Stanford University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
| The State University of New York | College/University | Doctorate Degree Doctorate Degree | |
AlloCure, Inc.
 AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Biotechnology | Corporate Officer/Principal | |
Deep Genomics, Inc.
 Deep Genomics, Inc. BiotechnologyHealth Technology Deep Genomics, Inc. provides machine learning, genome biology and precision medicine. It develops an integrated computational system that could learn, predict, and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The firm offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome. Its SPIDEX database covers all synonymous, missense, and nonsense exonic SNVs, as well as intronic SNVs that are up to 300nt from splice junctions. The company was founded by Brendan Frey and Hui Yuan Xiong in 2015 and is headquartered in Toronto, Canada. | Biotechnology | Chief Executive Officer | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Imagen Biotech, Inc.
 Imagen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Imagen Biotech, Inc. develops therapeutics for sight-threatening diseases. The firm specializes in personalized chemotherapy, medicine, high content screening, cell biology and contract research. The company was founded by David R. Guyer and Matthew Feinsod in 2011 and is headquartered in New York, NY. | Pharmaceuticals: Major | President | |
| Sonrgy, Inc. | Chief Executive Officer | ||
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| INDAPTUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Founder | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VAXCYTE, INC. | Biotechnology | Founder | |
Pivotal Bioventure Partners Investment Advisor LLC
 Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Evommune, Inc.
 Evommune, Inc. Miscellaneous Commercial ServicesCommercial Services Evommune, Inc. engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pe?a, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Los Altos, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Fountain Therapeutics, Inc.
 Fountain Therapeutics, Inc. BiotechnologyHealth Technology Fountain Therapeutics, Inc. develops treatment for aging-associated diseases. The company is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
| NTG NORDIC TRANSPORT GROUP A/S | Trucking | Corporate Officer/Principal | |
7TM A/S
 7TM A/S Pharmaceuticals: MajorHealth Technology 7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark. | Pharmaceuticals: Major | Founder | |
| Danmarks Farmaceutiske Universitet | College/University | Doctorate Degree | |
Cardeas Pharma Corp.
 Cardeas Pharma Corp. Pharmaceuticals: MajorHealth Technology Cardeas Pharma Corp. develops drugs for the prevention of ventilator associated pneumonia. It offers a novel antibiotic formulation of two drugs with synergistic activity against relevant, resistant Gram-negative bacilli, including pseudomonas aeruginosa, acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. The company was founded by Alan Bruce Montgomery on November 23, 2011 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Decoy Biosystems, Inc.
 Decoy Biosystems, Inc. BiotechnologyHealth Technology Decoy Biosystems, Inc. provides cancer immunotherapy services. The company was founded on August 14, 2013 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
| Haas School of Business | College/University | Masters Business Admin |
Statistics
International
| United States | 37 |
| Denmark | 7 |
| Switzerland | 3 |
| Canada | 3 |
| India | 2 |
Sectoral
| Health Technology | 34 |
| Consumer Services | 10 |
| Finance | 5 |
| Commercial Services | 3 |
| Transportation | 2 |
Operational
| Director/Board Member | 175 |
| Corporate Officer/Principal | 59 |
| Independent Dir/Board Member | 51 |
| Founder | 31 |
| Chief Executive Officer | 26 |
Most connected contacts
| Insiders | |
|---|---|
| James Healy | 50 |
| Kathy LaPorte | 34 |
| Mahendra Shah | 34 |
| Edgar Engleman | 29 |
| Peter Moldt | 25 |
| Brian O'Callaghan | 20 |
| Nicole Onetto | 17 |
| Richard Miller | 13 |
| Frank Lee | 13 |
| Ashish Khanna | 12 |
| William Quinn | 11 |
| Laurie C. Torres | 11 |
| Randall Schatzman | 9 |
| Grant Yonehiro | 9 |
| Jason Pitts | 9 |
- Stock Market
- Insiders
- John Tomaro
- Company connections
